DE69231955D1 - Verwendung von N-(2,6-Dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamid zur Behandlung von Demenz - Google Patents
Verwendung von N-(2,6-Dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamid zur Behandlung von DemenzInfo
- Publication number
- DE69231955D1 DE69231955D1 DE69231955T DE69231955T DE69231955D1 DE 69231955 D1 DE69231955 D1 DE 69231955D1 DE 69231955 T DE69231955 T DE 69231955T DE 69231955 T DE69231955 T DE 69231955T DE 69231955 D1 DE69231955 D1 DE 69231955D1
- Authority
- DE
- Germany
- Prior art keywords
- dementia
- dimethylphenyl
- pyrrolidinyl
- acetamide
- oxo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/4015—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having oxo groups directly attached to the heterocyclic ring, e.g. piracetam, ethosuximide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pyrrole Compounds (AREA)
- Materials For Medical Uses (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP22981891 | 1991-05-02 | ||
JP22981991 | 1991-05-02 |
Publications (2)
Publication Number | Publication Date |
---|---|
DE69231955D1 true DE69231955D1 (de) | 2001-08-30 |
DE69231955T2 DE69231955T2 (de) | 2002-04-04 |
Family
ID=26529012
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69231955T Expired - Lifetime DE69231955T2 (de) | 1991-05-02 | 1992-04-30 | Verwendung von N-(2,6-Dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamid zur Behandlung von Demenz |
Country Status (22)
Country | Link |
---|---|
US (1) | US5886023A (de) |
EP (1) | EP0515866B1 (de) |
KR (1) | KR100310590B1 (de) |
AT (1) | ATE203402T1 (de) |
AU (2) | AU1595492A (de) |
CA (1) | CA2067614C (de) |
CZ (1) | CZ281170B6 (de) |
DE (1) | DE69231955T2 (de) |
DK (1) | DK0515866T3 (de) |
ES (1) | ES2160097T3 (de) |
GR (1) | GR3036970T3 (de) |
HK (1) | HK1002153A1 (de) |
HU (1) | HU224689B1 (de) |
IE (1) | IE921377A1 (de) |
IL (1) | IL101738A (de) |
MX (1) | MX9202058A (de) |
NO (1) | NO312813B1 (de) |
PT (1) | PT515866E (de) |
RU (1) | RU2070042C1 (de) |
SG (1) | SG49650A1 (de) |
SK (1) | SK279285B6 (de) |
TW (1) | TW199096B (de) |
Families Citing this family (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20000048847A (ko) * | 1996-10-01 | 2000-07-25 | 스즈키 다다시 | 미토콘드리아 막 안정화제 |
KR20010021897A (ko) | 1997-07-15 | 2001-03-15 | 스즈키 다다시 | 건망증의 예방 또는 치료약 |
US20040077709A1 (en) * | 1999-05-31 | 2004-04-22 | Daiichi Pharmaceutical Co., Ltd. | Neuronal death inhibitors |
CN1368882A (zh) * | 1999-05-31 | 2002-09-11 | 第一制药株式会社 | 神经元死亡抑制剂 |
US6376489B1 (en) * | 1999-12-23 | 2002-04-23 | Icos Corporation | Cyclic AMP-specific phosphodiesterase inhibitors |
US6423739B1 (en) * | 2000-02-23 | 2002-07-23 | Daiichi Pharmaceutical Co., Ltd. | Method for aiding cerebral recovery following neurodegeneration |
GB0004297D0 (en) * | 2000-02-23 | 2000-04-12 | Ucb Sa | 2-oxo-1 pyrrolidine derivatives process for preparing them and their uses |
US6348489B1 (en) * | 2000-04-11 | 2002-02-19 | Daiichi Pharmaceutical Co., Ltd. | Method of treating traumatic brain injury and other neuronal disorders |
WO2002053153A1 (fr) * | 2000-12-28 | 2002-07-11 | Daiichi Pharmaceutical Co., Ltd. | Medicaments permettant de traiter et de prevenir une douleur neurologique |
ATE404192T1 (de) * | 2001-08-22 | 2008-08-15 | Hamilton Pharmaceuticals Inc | Verwendung von nefiracetam zur behandlung von postischemischer neurodegeneration |
US20060241144A1 (en) * | 2005-04-20 | 2006-10-26 | Albert Cha | Method for treating apathy syndrome |
US7972633B2 (en) * | 2007-02-07 | 2011-07-05 | Applied Cognitive Sciences, LLC | Nutritional supplements for healthy memory and mental function |
EA033130B1 (ru) * | 2008-10-16 | 2019-08-30 | Дзе Джонс Хопкинс Юниверсити | Способы и композиции для улучшения когнитивной функции |
US20110212928A1 (en) * | 2010-02-09 | 2011-09-01 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
EP2919788A4 (de) | 2012-11-14 | 2016-05-25 | Univ Johns Hopkins | Verfahren und zusammensetzungen zur behandlung von schizophrenie |
US10806717B2 (en) | 2013-03-15 | 2020-10-20 | The Johns Hopkins University | Methods and compositions for improving cognitive function |
ES2881081T3 (es) | 2013-03-15 | 2021-11-26 | Agenebio Inc | Procedimientos y composiciones para mejorar la función cognitiva |
JP6899043B2 (ja) | 2015-05-22 | 2021-07-07 | エージンバイオ, インコーポレイテッド | レベチラセタムの持続放出性医薬組成物 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BE864269A (fr) * | 1977-03-03 | 1978-06-16 | Parke Davis & Co | Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides et procedes pour les produire |
IT1141287B (it) * | 1979-06-13 | 1986-10-01 | Nattermann A & Cie | Ammidi di acidi pirrolidin-(2)-on-(1)-ilalchil-carbossilici,procedimento per la loro preparazione e prodotti medicinali che le contengono |
US4385053A (en) * | 1981-03-11 | 1983-05-24 | Barry Reisberg | Treatment for human memory impairment associated with aging |
JPH0699307B2 (ja) * | 1987-08-20 | 1994-12-07 | キッセイ薬品工業株式会社 | 抗痴呆剤 |
IT1231477B (it) * | 1989-07-12 | 1991-12-07 | Sigma Tau Ind Farmaceuti | (pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti |
-
1992
- 1992-04-29 SK SK1306-92A patent/SK279285B6/sk unknown
- 1992-04-29 CZ CS921306A patent/CZ281170B6/cs not_active IP Right Cessation
- 1992-04-29 CA CA002067614A patent/CA2067614C/en not_active Expired - Lifetime
- 1992-04-30 MX MX9202058A patent/MX9202058A/es not_active IP Right Cessation
- 1992-04-30 HU HU9201477A patent/HU224689B1/hu not_active IP Right Cessation
- 1992-04-30 DE DE69231955T patent/DE69231955T2/de not_active Expired - Lifetime
- 1992-04-30 NO NO19921724A patent/NO312813B1/no unknown
- 1992-04-30 IL IL10173892A patent/IL101738A/en active IP Right Grant
- 1992-04-30 PT PT92107421T patent/PT515866E/pt unknown
- 1992-04-30 RU SU5011760/14A patent/RU2070042C1/ru not_active IP Right Cessation
- 1992-04-30 AT AT92107421T patent/ATE203402T1/de not_active IP Right Cessation
- 1992-04-30 DK DK92107421T patent/DK0515866T3/da active
- 1992-04-30 ES ES92107421T patent/ES2160097T3/es not_active Expired - Lifetime
- 1992-04-30 SG SG1996002798A patent/SG49650A1/en unknown
- 1992-04-30 EP EP92107421A patent/EP0515866B1/de not_active Expired - Lifetime
- 1992-05-01 KR KR1019920007433A patent/KR100310590B1/ko not_active IP Right Cessation
- 1992-05-01 TW TW081103420A patent/TW199096B/zh active
- 1992-05-01 AU AU15954/92A patent/AU1595492A/en not_active Abandoned
- 1992-07-01 IE IE137792A patent/IE921377A1/en not_active IP Right Cessation
-
1995
- 1995-05-22 US US08/447,054 patent/US5886023A/en not_active Expired - Fee Related
- 1995-11-08 AU AU37745/95A patent/AU697936B2/en not_active Ceased
-
1998
- 1998-01-21 HK HK98100554A patent/HK1002153A1/xx not_active IP Right Cessation
-
2001
- 2001-10-22 GR GR20010401840T patent/GR3036970T3/el not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
NO312813B1 (no) | 2002-07-08 |
GR3036970T3 (en) | 2002-01-31 |
HK1002153A1 (en) | 1998-07-31 |
HUT62790A (en) | 1993-06-28 |
EP0515866B1 (de) | 2001-07-25 |
DE69231955T2 (de) | 2002-04-04 |
KR100310590B1 (ko) | 2001-12-28 |
US5886023A (en) | 1999-03-23 |
MX9202058A (es) | 1993-03-01 |
TW199096B (de) | 1993-02-01 |
CA2067614C (en) | 2002-07-30 |
KR920021143A (ko) | 1992-12-18 |
AU1595492A (en) | 1992-11-05 |
HU224689B1 (hu) | 2005-12-28 |
IE921377A1 (en) | 1992-11-04 |
SK279285B6 (sk) | 1998-09-09 |
CS130692A3 (en) | 1992-11-18 |
CZ281170B6 (cs) | 1996-07-17 |
IL101738A (en) | 1999-01-26 |
SG49650A1 (en) | 1998-06-15 |
EP0515866A1 (de) | 1992-12-02 |
IL101738A0 (en) | 1992-12-30 |
HU9201477D0 (en) | 1992-07-28 |
ES2160097T3 (es) | 2001-11-01 |
ATE203402T1 (de) | 2001-08-15 |
CA2067614A1 (en) | 1992-11-03 |
PT515866E (pt) | 2001-11-30 |
NO921724D0 (no) | 1992-04-30 |
NO921724L (no) | 1992-11-03 |
RU2070042C1 (ru) | 1996-12-10 |
AU697936B2 (en) | 1998-10-22 |
DK0515866T3 (da) | 2001-09-24 |
AU3774595A (en) | 1996-03-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69231955D1 (de) | Verwendung von N-(2,6-Dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamid zur Behandlung von Demenz | |
DE59109222D1 (de) | Verwendung des Wirkstoffs Flupirtin zur Herstellung eines Arzneimittels zur Bekämpfung von Muskelverspannungen | |
ATE114113T1 (de) | Verwendung von droloxifen bei der behandlung von knochenerkrankungen. | |
ATE184792T1 (de) | 2-bromomelatonin zur behandlung von schlafstörungen | |
DE69310065D1 (de) | Verwendung von 2-(3,4-Dimethoxycinnamoyl)aminobenzoesäure zur Herstellung eines Arzeimittels zur Behandlung der Restenose | |
DE69422450D1 (de) | Chinoline oder Chinazolin-Derivate und deren Verwendung zur Herstellung eines Medikaments für die Behandlung von Osteoporose | |
NO167913C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive triamine | |
FI961809A0 (fi) | Uudet (R)-5-karbamoyyli-8-fluori-3-N,N-disubstituoitu-amino 3,4-dihydro-2H-1-bentsopyraanit | |
DE69232323D1 (de) | Verwendung von Adenosinantagonisten zur Vorbeugung und Behandlung von Pankreatitis und Ulcera | |
ATE269066T1 (de) | Kombinationstherapie zur prophylaxe und/oder behandlung von gutartiger prostatischer hyperplasie | |
ATE141505T1 (de) | Verwendung von 3-guanidinopropionsäure zur herstellung eines medikaments zur behandlung und prävention von fettsucht | |
ATE167060T1 (de) | Epidermis-wachstumsfaktor als arzneimittel zur wiederherstellung der neuronen der substantia nigra in der behandlung nervenzerstörender störungen | |
NO179472C (no) | Opplösning omfattende benzoxoniumklorid for behandling av kontaktlinser, og anvendelse derav til konservering av kontaktlinser og legemidler for öynene | |
ATE193450T1 (de) | Pharmazeutische zusammensetzung zur vorbeugung oder behandlung von knochenbrüchen | |
DE69326188D1 (de) | Verwendung von N-Acylderivaten von Aminoalkoholen zur Herstellung eines Arzneimittels zur Behandlung von neurogenen endoneuralen Ödemen der peripheren Nerven | |
DE69300037D1 (de) | Verwendung von Bucillamin zur Herstellung eines Arzneimittels zur Behandlung von Cystinuria. | |
DE68901172D1 (de) | (-)-2-pyrazolinverbindung, deren optischen aufspaltung und therapeutisches agens zur behandlung von zerebralen gefaesskrankheiten, diese verbindung als aktives ingredient enthaltend. | |
DE69124415D1 (de) | Verwendung von 15-Dehydroxy-16-Oxoprostaglandin bei der Behandlung von allergischen Erkrankungen | |
DK0826373T3 (da) | Forebyggende middel mod postoperativ astigmatisme | |
NO921525D0 (no) | L-alfa-glyserofosforyl-d-myo-inositol for behandling av perifere nervelidelser og hjernelidelser | |
DE3585312D1 (de) | Anwendung von 1,6-dimethyl-4-oxo-1,6,7,8,9a-hexahydro-4h-pyrido(1,2-a)pyrimidin-3-carboxamid zur vorbeugung und behandlung von gastrointestinalschaeden. | |
ATE91234T1 (de) | Verwendung von dimetylheptylphenylbutanoylethanolamin bei der behandlung von hyperuricemie. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8364 | No opposition during term of opposition | ||
8327 | Change in the person/name/address of the patent owner |
Owner name: HAMILTON PHARMACEUTICALS, INC., PALO ALTO, CALIF., |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: HAMILTON PHARAMCEUTICALS, INC., WASHINGTON, D.C., |